# Reinforced Pancreaticojejunostomy With or Without glubran2

Source: https://onco.cc/trials/nct06756074/  
OnCo record `nct06756074` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial in pancreatic cancer, run by Minia University, now recruiting.

## Summary

Reinforced Pancreaticojejunostomy With or Without glubran2 is a phase 2, randomised interventional study registered as NCT06756074 by Minia University, with a registry enrolment figure of 100 participants, started 2025-01-15 and due to reach its primary completion in 2026-04-15. Interventions recorded: Reinforced pancreaticojejunostomy with tissue adhesive glue modified cyanoacrylate (glubran 2); Pancreaticojejunostomy without tissue adhesive glue modified cyanoacrylate (glubran 2). Conditions listed: Pancreatic Fistula; Pancreas Cancer; Periampullary Carcinoma; Pancreatic Ductal Adenocarcinoma. Primary outcome: the rate of Postoperative pancreatic fistula within 2 weeks after operation. Pancreatic eligibility wording from the registry: "* All the patients undergoing pancreaticoduodenectomy for cancer". Sites: Egypt. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-24
- Tags: ctgov-ingest; pancreatic-deep-dive
- Registry id: NCT06756074
- Phase: 2
- Setting: Impact of Reinforced Pancreaticojejunostomy With or Without Tissue Adhesive Glue Modified Cyanoacrylate (Glubran 2) Following Pancreaticoduodenectomy, Randomized Controlled Clinical Trial.
- Sponsor: Minia University
- Enrolled: 100

## Sources

- ClinicalTrials.gov NCT06756074: https://clinicaltrials.gov/study/NCT06756074

## Connected records

- cancers: [Resectable pancreatic ductal adenocarcinoma](https://onco.cc/cancers/resectable-pdac/)
- terms: [Pancreatic cancer trials open today (registry snapshot and UK sites)](https://onco.cc/terms/pancreatic-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct06756074.json